Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

被引：0
作者：
Sean Duffy
Robert Marron
Helen Voelker
Richard Albert
John Connett
William Bailey
Richard Casaburi
J. Allen Cooper
Jeffrey L. Curtis
Mark Dransfield
MeiLan K. Han
Barry Make
Nathaniel Marchetti
Fernando Martinez
Stephen Lazarus
Dennis Niewoehner
Paul D. Scanlon
Frank Sciurba
Steven Scharf
Robert M. Reed
George Washko
Prescott Woodruff
Charlene McEvoy
Shawn Aaron
Don Sin
Gerard J. Criner
机构：
[1] Lewis Katz School of Medicine at Temple University,Department of Thoracic Medicine and Surgery
[2] University of Minnesota,Department of Thoracic Medicine and Surgery
[3] Denver Health Medical Center,undefined
[4] University of Alabama at Birmingham,undefined
[5] Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center,undefined
[6] University of Michigan Health System,undefined
[7] National Jewish Health,undefined
[8] Weill Cornell Medical College of Cornell University,undefined
[9] Univ of California San Francisco,undefined
[10] Minneapolis VA Medical Center,undefined
[11] Mayo Clinic,undefined
[12] University of Pittsburgh Medical Center,undefined
[13] University of Maryland,undefined
[14] Brigham & Women’s Hospital,undefined
[15] HealthPartners,undefined
[16] The Ottawa Hospital Research Institute,undefined
[17] Providence Heart + Lung Institute,undefined
[18] Temple University School of Medicine,undefined
来源：
Respiratory Research | / 18卷
关键词：
COPD; Exacerbation; Beta-blocker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 70 条
[1]  
Tashkin DP(2008)A 4 years trial of tiotropium in chronic obstructive pulmonary disease N Engl J Med 359 1543-1554
[2]  
Celli B(2007)Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease N Eng J Med 356 775-789
[3]  
Senn S(2014)Simvastatin for the prevention of exacerbations in moderate-to-severe COPD N Eng J Med 370 2201-10
[4]  
Burkhart D(2011)Azithromycin for prevention of exacerbations of COPD N Engl J Med 365 689-98
[5]  
Kesten S(1997)The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 157 2413-46
[6]  
Menjoge S(2005)Detrimental effects of beta-blockers in COPD: a concern for nonselective beta-blockers Chest 127 818-24
[7]  
Decramer M(2005)Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease QJ Med 98 493-7
[8]  
Calverly PMA(2005)Cardioselective beta-blockers in patients with reactive airway disease: a meta analysis Cochrane Database Syst Rev 19 CD003566-887
[9]  
Anderson JA(2012)Beta blocker use and COPD mortality: a systematic review and meta-analysis BMC Pulm Med 12 48-23
[10]  
Celli B(2014)Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies PLoS One 9 e113048-931
1234567